Wednesday, December 24, 2008 FDA Approves Ferring Pharmaceuticals' Degarelix (Generic Name) for Treatment of Advanced Prostate Cancer |More| Thursday, December 18, 2008 Committee for Medicinal Products for Human Use (CHMP) recommends granting marketing authorisation for FIRMAGON® (degarelix) for treatment of prostate cancer New gonadtropin-releasing hormone (GnRH) receptor antagonist demonstrates rapid, long-term suppression of testosterone |More| Wednesday, December 10, 2008 Ferring and Conaris complete license agreement for new recombinant molecule in gastroenterology |More| Wednesday, December 03, 2008 Ferring signs distribution agreement with BioGaia in Ireland and the Middle East. |More| Monday, December 01, 2008 Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim® in Europe with Ferring Pharmaceuticals |More| Thursday, March 27, 2008 Positive phase III data unveiled for new GnRH blocker degarelix |More| Thursday, February 28, 2008 Ferring Pharmaceuticals submits new drug application for degarelix, a prostate cancer treatment |More| Wednesday, January 30, 2008 Launch of new, prestigious infertility and gynaecology research grant (FRIGGA) at "Update in Infertility 2008" |More|

© Copyright Label Ferring. All world rights reserved.

|  Event Calendar |  Global Locator |  Search |  FAQS |  Sitemap |  Legal Disclaimer